Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?

被引:1
|
作者
Samson, M. [1 ,2 ,3 ]
Bonnotte, B. [1 ,2 ,3 ]
机构
[1] CHU Dijon Bourgogne, Serv Med Interne, 2 Blvd Mal de Lattre de Tassigny, F-21000 Dijon, France
[2] CHU Dijon Bourgogne, Immunol Clin, 2 Blvd Mal de Lattre de Tassigny, F-21000 Dijon, France
[3] Univ Bourgogne Franche Comte, FHU Increase, Inserm U1098, F-21000 Dijon, France
来源
REVUE DE MEDECINE INTERNE | 2018年 / 39卷 / 02期
关键词
Giant cell arteritis; Treatment; Tocilizumab; LARGE-VESSEL VASCULITIS; TAKAYASU ARTERITIS; DOUBLE-BLIND; THERAPY; TRIAL; ABATACEPT;
D O I
10.1016/j.revmed.2017.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:75 / 77
页数:3
相关论文
共 50 条
  • [21] Tocilizumab for giant cell arteritis: an amazing result
    Isik, Metin
    Kilic, Levent
    Dogan, Ismail
    Calguneri, Meral
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) : 2961 - 2962
  • [22] Trial of Tocilizumab in Giant-Cell Arteritis REPLY
    Stone, John H.
    Klearman, Micki
    Collinson, Neil
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (15): : 1494 - 1495
  • [23] Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits
    Buttgereit, Frank
    Palmowski, Andriko
    Esen, Idil
    Brouwer, Elisabeth
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (04) : 489 - 492
  • [24] Primary Treatment Failure to Tocilizumab in Giant Cell Arteritis
    Cioni, Paul
    de Boysson, Hubert
    Parreau, Simon
    Smets, Perrine
    Samson, Maxime
    Melboucy, Sara
    Lobbes, Herve
    Belfeki, Nabil
    Perrin, Francois
    Rossi, Pascal Maurice
    Liozon, Eric
    Le Guenno, Guillaume
    Le Jeunne, Claire
    Fogel, Olivier
    Prat, Lola
    Ladouce, Florent
    Grosleron, Sylvie
    Yildiz, Halil
    Grosbost, Vincent
    Puechal, Xavier
    Comarmond, Chloe
    Terrier, Benjamin
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1596 - 1598
  • [25] EFFICACY OF TOCILIZUMAB IN 31 PATIENTS WITH GIANT CELL ARTERITIS
    Dominguez-Casas, L. C.
    Loricera, J.
    Hernandez, J. L.
    Castaneda, S.
    Mera, A.
    Perez-Pampin, E.
    Peiro, E.
    Humbria, A.
    Calvo-Alen, J.
    Aurrecoechea, E.
    Narvaez, J.
    Sanchez-Andrade, A.
    Vela, P.
    Diez, E.
    Mariano, C.
    Lluch, P.
    Moll, C.
    Hernandez, I.
    Calvo-Rio, V.
    Ivorra, J.
    Corrales, A.
    Ortiz-Sanjuan, F.
    Gonzalez-Vela, C.
    Gonzalez-Gay, M. A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 614 - 614
  • [26] Tocilizumab: an effective treatment for relapsing giant cell arteritis
    Oliveira, F.
    Butendieck, R. R.
    Ginsburg, W. W.
    Parikh, K.
    Abril, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S76 - S78
  • [27] Comment on: Benchmarking tocilizumab use for giant cell arteritis
    Janagan, Shalini
    Guly, Catherine
    Skeoch, Sarah
    Robson, Joanna C.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (03)
  • [28] Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study
    Muratore, Francesco
    Marvisi, Chiara
    Cassone, Giulia
    Boiardi, Luigi
    Mancuso, Pamela
    Besutti, Giulia
    Spaggiari, Lucia
    Casali, Massimiliano
    Croci, Stefania
    Versari, Annibale
    Rossi, Paolo Giorgi
    Catanoso, Mariagrazia
    Costantini, Massimo
    Galli, Elena
    Salvarani, Carlo
    RHEUMATOLOGY, 2024, 63 (01) : 64 - 71
  • [29] Treatment of Giant Cell Arteritis Patients with Ultra-short Glucocorticoids and Tocilizumab: Role of Imaging in a Prospective Study
    Muratore, Francesco
    Cassone, Giulia
    Marvisi, Chiara
    Galli, Elena
    Boiardi, Luigi
    Besutti, Giulia
    Spaggiari, Lucia
    Casali, Massimiliano
    Mancuso, Pamela
    Versari, Annibale
    Rossi, Paolo Giorgi
    Salvarani, Carlo
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 956 - 958
  • [30] TREATMENT OF GIANT CELL ARTERITIS PATIENTS WITH ULTRA-SHORT GLUCOCORTICOIDS AND TOCILIZUMAB: ROLE OF IMAGING IN A PROSPECTIVE STUDY
    Muratore, F.
    Cassone, G.
    Marvisi, C.
    Galli, E.
    Boiardi, L.
    Besutti, G.
    Spaggiari, L.
    Casali, M.
    Mancuso, P.
    Versari, A.
    Rossi, P. Giorgi
    Salvarani, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 633 - 633